Uber shares rise in premarket as Wayve’s London robotaxi license clears a key regulatory step ahead of Q2 earnings

Uber’s stock climbed in premarket trading as investors looked ahead to the company’s second-quarter earnings and to a potential acceleration of robotaxi testing tied to its partnership with autonomous-driving startup Wayve.

The move was linked to a reported regulatory milestone in London for Wayve. According to the market report circulating on the Uber stock discussion feeds, Wayve received a key London license, a step described as clearing a hurdle for public robotaxi trials on the platform.

While the report does not provide additional operational details, the implication for investors is straightforward: local authorization is typically one of the gating items for companies pursuing real-world, on-road testing and pilot operations for autonomous vehicles.

Uber’s business has been increasingly shaped by expectations around how quickly advanced automation can move from limited pilots to broader deployment. In that context, a partner’s ability to expand testing within a major city can become a announcement that technical progress and regulatory navigation are both moving in the right direction.

Uber is also approaching its quarterly earnings readout, which often acts as a near-term catalyst for the stock, especially when autonomy-linked developments are in focus. The market report frames the price action as occurring “ahead of Q2 earnings,” suggesting traders were positioning for updates on growth, margins, and any business line changes that could influence investor sentiment.

Sector context matters here. The autonomous-vehicle market has been defined by uneven timelines, where progress is frequently dictated as much by permissions, safety cases, and city-level approvals as by model performance. A license tied to trials in a specific jurisdiction can therefore become a meaningful checkpoint even when full commercial rollout remains uncertain.

Still, important details are not disclosed in the report. It does not specify the size or scope of the licensed trial, the timeline for when public robotaxi service could begin, vehicle types or safety constraints, or whether the license directly covers any production-like service versus limited testing and monitoring.

For now, the key question for the next phase is whether Uber and Wayve can convert this regulatory step into measurable trial outcomes that support further permissions. Investors will likely look for more concrete updates around the timetable and scope of London operations, alongside what Uber reports in its Q2 results about costs, timelines, and strategic priorities.